Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Stemline Therapeutics, Inc. 401(K) Plan is a benefit plan reported by Stemline Therapeutics, Inc. under EIN 45-0522567 and plan number 001. The latest loaded filing year is 2023. The filing reports 269 participants and $23,535,996 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $23,535,996
- Net assets (EOY)
- $23,535,996
- Net assets (BOY)
- $11,982,170
Income & contributions
- Employer contributions
- $2,686,806
- Participant contributions
- $5,437,984
- Total contributions
- $10,356,321
- Total income / additions
- $13,529,636
Expenses & distributions
- Benefits paid
- $1,921,250
- Administrative expenses
- $8,751
- Total expenses
- $1,975,810
- Net increase / (decrease)
- $11,553,826